Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
VACANCY | Science and Innovation Manager
Planet B.io is looking for a Science and Innovation manager to support and grow our community of start-ups, scale-ups, and corporates in the biotech and foodtech sector.
One year later: Insights from Scale-up frontrunners | Mickel Jansen (dsm-firmenich)
Mickel Jansen, Principal Scientist BioProcess Development of dsm-firmenich, shares last year’s improvements and reflects on scaling, innovation, and keeping the end in mind.
Fenneke Jolink
One year later: Insights from Scale-up frontrunners | Robyn Eijlander (NIZO)
Robyn Eijlander, Science Innovation Manager and Program Manager at NIZO and BFF, shares last year’s improvements and shows off a nice bracelet.
Fenneke Jolink